三力制药
(603439)
| 流通市值：47.73亿 | | | 总市值：48.34亿 |
| 流通股本：4.04亿 | | | 总股本：4.09亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 265,692,689.23 | 283,547,177.02 | 363,887,509.63 | 474,845,014.34 |
| 交易性金融资产 | 59,704,659.21 | 19,500,145.21 | 55,335,081.52 | 22,945,081.52 |
| 应收票据及应收账款 | 621,045,391.61 | 705,649,507.19 | 826,069,699.13 | 810,732,357.32 |
| 其中：应收票据 | 71,991,077.1 | 57,651,599.69 | 56,678,748.09 | 82,062,569.1 |
| 应收账款 | 549,054,314.51 | 647,997,907.5 | 769,390,951.04 | 728,669,788.22 |
| 应收款项融资 | 79,529,317.02 | 64,091,536.64 | 85,933,818.02 | 121,388,452.65 |
| 预付款项 | 46,814,305.34 | 46,077,575.75 | 35,635,112.18 | 33,687,505.24 |
| 其他应收款合计 | 4,672,194.22 | 5,002,984.13 | 6,205,627.19 | 7,099,346.97 |
| 存货 | 324,732,952.16 | 364,371,508.34 | 347,636,773.07 | 320,722,064.52 |
| 其他流动资产 | 7,038,570.3 | 6,879,071.69 | 5,730,338.81 | 6,565,499.28 |
| 流动资产合计 | 1,409,230,079.09 | 1,495,119,505.97 | 1,726,433,959.55 | 1,797,985,321.84 |
| 非流动资产: | | | | |
| 长期股权投资 | 79,569,650.85 | 63,556,353.25 | 45,469,379.1 | 12,547,227.44 |
| 其他权益工具投资 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 |
| 投资性房地产 | 40,352,921.62 | - | - | - |
| 固定资产 | 492,739,715.7 | 545,647,306.46 | 551,185,231.39 | 563,914,039.44 |
| 在建工程 | - | 5,045.01 | 2,359 | - |
| 生产性生物资产 | 36,735,556.05 | 29,999,388.76 | 20,109,486.04 | 11,603,881.45 |
| 使用权资产 | 10,824,535.13 | 11,173,800.88 | 9,278,990.03 | 9,631,487.54 |
| 无形资产 | 198,948,230.61 | 206,591,589.5 | 211,359,904.34 | 216,128,219.15 |
| 商誉 | 554,606,134.6 | 554,606,134.6 | 554,606,134.6 | 554,606,134.6 |
| 长期待摊费用 | 638,973.03 | 721,791.16 | 560,396.05 | 562,691.2 |
| 递延所得税资产 | 14,522,736.46 | 15,414,814.29 | 15,363,299.55 | 15,128,887.97 |
| 非流动资产合计 | 1,438,938,454.05 | 1,437,716,223.91 | 1,417,935,180.1 | 1,394,122,568.79 |
| 资产总计 | 2,848,168,533.14 | 2,932,835,729.88 | 3,144,369,139.65 | 3,192,107,890.63 |
| 流动负债: | | | | |
| 短期借款 | 575,483,713.08 | 542,926,654.78 | 486,556,352.53 | 351,521,547.18 |
| 应付票据及应付账款 | 135,350,911.84 | 235,084,278.81 | 315,166,930.59 | 360,623,598.69 |
| 应付账款 | 135,350,911.84 | 235,084,278.81 | 315,166,930.59 | 360,623,598.69 |
| 合同负债 | 7,744,383.74 | 7,301,847.73 | 7,718,675.32 | 7,790,038.48 |
| 应付职工薪酬 | 4,419,905.17 | 3,609,222.96 | 11,215,122.44 | 22,651,658.65 |
| 应交税费 | 20,234,964.81 | 17,598,139.72 | 29,108,524.91 | 72,637,959.4 |
| 其他应付款合计 | 161,817,927.06 | 177,315,040.93 | 226,014,229.93 | 351,280,861.5 |
| 应付股利 | 890 | 890 | - | 550 |
| 一年内到期的非流动负债 | 52,714,082.47 | 52,763,259.66 | 45,274,298.21 | 45,648,207.95 |
| 其他流动负债 | 15,601,672.89 | 18,371,385.97 | 21,380,067.67 | 22,302,970.52 |
| 流动负债合计 | 973,367,561.06 | 1,054,969,830.56 | 1,142,434,201.6 | 1,234,456,842.37 |
| 非流动负债: | | | | |
| 长期借款 | 179,400,000 | 179,400,000 | 209,300,000 | 209,300,000 |
| 租赁负债 | 53,490.61 | 164,116.61 | 400,299.44 | 211,539.96 |
| 长期应付款 | 7,674,313.16 | 7,849,411.33 | 8,025,254.26 | 8,287,850.8 |
| 递延收益 | 39,906,386.86 | 40,927,878.16 | 41,949,369.43 | 42,970,860.79 |
| 递延所得税负债 | 22,865,567.3 | 23,737,678.79 | 24,639,234.99 | 25,498,918.59 |
| 其他非流动负债 | 76,754,836.2 | 76,754,836.2 | 76,754,836.2 | 76,754,836.2 |
| 非流动负债合计 | 326,654,594.13 | 328,833,921.09 | 361,068,994.32 | 363,024,006.34 |
| 负债合计 | 1,300,022,155.19 | 1,383,803,751.65 | 1,503,503,195.92 | 1,597,480,848.71 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 409,802,216 | 409,802,216 | 409,802,216 | 409,802,216 |
| 资本公积 | 159,234,433.14 | 155,962,103.18 | 152,586,794.03 | 149,042,263.82 |
| 减:库存股 | 100,642,385.06 | 100,642,385.06 | 100,642,385.06 | 100,642,385.06 |
| 盈余公积 | 133,275,177.34 | 133,275,177.34 | 133,275,177.34 | 133,275,177.34 |
| 未分配利润 | 879,011,297.22 | 881,285,287.74 | 977,809,900.19 | 935,863,129.35 |
| 归属于母公司股东权益合计 | 1,480,680,738.64 | 1,479,682,399.2 | 1,572,831,702.5 | 1,527,340,401.45 |
| 少数股东权益 | 67,465,639.31 | 69,349,579.03 | 68,034,241.23 | 67,286,640.47 |
| 股东权益合计 | 1,548,146,377.95 | 1,549,031,978.23 | 1,640,865,943.73 | 1,594,627,041.92 |
| 负债和股东权益合计 | 2,848,168,533.14 | 2,932,835,729.88 | 3,144,369,139.65 | 3,192,107,890.63 |
| 公告日期 | 2025-10-28 | 2025-08-28 | 2025-04-23 | 2025-04-23 |
| 审计意见(境内) | | | | 标准无保留意见 |